These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 32030510)
21. Assessment of Functional Phosphatidylinositol 3-Kinase Pathway Activity in Cancer Tissue Using Forkhead Box-O Target Gene Expression in a Knowledge-Based Computational Model. van Ooijen H; Hornsveld M; Dam-de Veen C; Velter R; Dou M; Verhaegh W; Burgering B; van de Stolpe A Am J Pathol; 2018 Sep; 188(9):1956-1972. PubMed ID: 30030980 [TBL] [Abstract][Full Text] [Related]
22. A novel phosphatidylinositol 3-kinase (PI3K) inhibitor directs a potent FOXO-dependent, p53-independent cell cycle arrest phenotype characterized by the differential induction of a subset of FOXO-regulated genes. Hill R; Kalathur RK; Callejas S; Colaço L; Brandão R; Serelde B; Cebriá A; Blanco-Aparicio C; Pastor J; Futschik M; Dopazo A; Link W Breast Cancer Res; 2014 Dec; 16(6):482. PubMed ID: 25488803 [TBL] [Abstract][Full Text] [Related]
23. FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity. Sunayama J; Sato A; Matsuda K; Tachibana K; Watanabe E; Seino S; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C Stem Cells; 2011 Sep; 29(9):1327-37. PubMed ID: 21793107 [TBL] [Abstract][Full Text] [Related]
24. Inactivation of the forkhead transcription factor FoxO3 is essential for PKB-mediated survival of hematopoietic progenitor cells by kit ligand. Engström M; Karlsson R; Jönsson JI Exp Hematol; 2003 Apr; 31(4):316-23. PubMed ID: 12691919 [TBL] [Abstract][Full Text] [Related]
25. Overexpression of HepaCAM inhibits bladder cancer cell proliferation and viability through the AKT/FoxO pathway. Tang M; Zhao Y; Liu N; Chen E; Quan Z; Wu X; Luo C J Cancer Res Clin Oncol; 2017 May; 143(5):793-805. PubMed ID: 28229220 [TBL] [Abstract][Full Text] [Related]
26. PI3K/Akt and Stat3 signaling regulated by PTEN control of the cancer stem cell population, proliferation and senescence in a glioblastoma cell line. Moon SH; Kim DK; Cha Y; Jeon I; Song J; Park KS Int J Oncol; 2013 Mar; 42(3):921-8. PubMed ID: 23314408 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines. Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223 [TBL] [Abstract][Full Text] [Related]
28. PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoter. Pore N; Liu S; Haas-Kogan DA; O'Rourke DM; Maity A Cancer Res; 2003 Jan; 63(1):236-41. PubMed ID: 12517803 [TBL] [Abstract][Full Text] [Related]
29. Elevated FOXG1 and SOX2 in glioblastoma enforces neural stem cell identity through transcriptional control of cell cycle and epigenetic regulators. Bulstrode H; Johnstone E; Marques-Torrejon MA; Ferguson KM; Bressan RB; Blin C; Grant V; Gogolok S; Gangoso E; Gagrica S; Ender C; Fotaki V; Sproul D; Bertone P; Pollard SM Genes Dev; 2017 Apr; 31(8):757-773. PubMed ID: 28465359 [TBL] [Abstract][Full Text] [Related]
30. Dual inhibition of PI3K and mTORC1/2 signaling by NVP-BEZ235 as a new therapeutic strategy for acute myeloid leukemia. Chapuis N; Tamburini J; Green AS; Vignon C; Bardet V; Neyret A; Pannetier M; Willems L; Park S; Macone A; Maira SM; Ifrah N; Dreyfus F; Herault O; Lacombe C; Mayeux P; Bouscary D Clin Cancer Res; 2010 Nov; 16(22):5424-35. PubMed ID: 20884625 [TBL] [Abstract][Full Text] [Related]
31. Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers. O'Halloran PJ; Viel T; Murray DW; Wachsmuth L; Schwegmann K; Wagner S; Kopka K; Jarzabek MA; Dicker P; Hermann S; Faber C; Klasen T; Schäfers M; O'Brien D; Prehn JH; Jacobs AH; Byrne AT Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1673-83. PubMed ID: 26975402 [TBL] [Abstract][Full Text] [Related]
32. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells. Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279 [TBL] [Abstract][Full Text] [Related]
33. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Seoane J; Le HV; Shen L; Anderson SA; Massagué J Cell; 2004 Apr; 117(2):211-23. PubMed ID: 15084259 [TBL] [Abstract][Full Text] [Related]
34. IL-17A promotes cell migration and invasion of glioblastoma cells via activation of PI3K/AKT signalling pathway. Zheng Q; Diao S; Wang Q; Zhu C; Sun X; Yin B; Zhang X; Meng X; Wang B J Cell Mol Med; 2019 Jan; 23(1):357-369. PubMed ID: 30353649 [TBL] [Abstract][Full Text] [Related]
35. Dual PI3K/mTOR inhibitor NVP-BEZ235-induced apoptosis of hepatocellular carcinoma cell lines is enhanced by inhibitors of autophagy. Chang Z; Shi G; Jin J; Guo H; Guo X; Luo F; Song Y; Jia X Int J Mol Med; 2013 Jun; 31(6):1449-56. PubMed ID: 23588698 [TBL] [Abstract][Full Text] [Related]
36. Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis. Zhang R; Banik NL; Ray SK Neurochem Res; 2007 Dec; 32(12):2194-202. PubMed ID: 17616812 [TBL] [Abstract][Full Text] [Related]
37. Resveratrol decreases FoXO protein expression through PI3K-Akt-dependent pathway inhibition in H₂O₂-treated synoviocytes. Xu B; Wang G; Zhang J; Cao W; Chen X Histol Histopathol; 2017 Dec; 32(12):1305-1315. PubMed ID: 28211035 [TBL] [Abstract][Full Text] [Related]
38. FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics. Jacobs FM; van der Heide LP; Wijchers PJ; Burbach JP; Hoekman MF; Smidt MP J Biol Chem; 2003 Sep; 278(38):35959-67. PubMed ID: 12857750 [TBL] [Abstract][Full Text] [Related]
39. MSK1-Mediated β-Catenin Phosphorylation Confers Resistance to PI3K/mTOR Inhibitors in Glioblastoma. Wu S; Wang S; Zheng S; Verhaak R; Koul D; Yung WK Mol Cancer Ther; 2016 Jul; 15(7):1656-68. PubMed ID: 27196759 [TBL] [Abstract][Full Text] [Related]
40. Klotho enhances FoxO3-mediated manganese superoxide dismutase expression by negatively regulating PI3K/AKT pathway during tacrolimus-induced oxidative stress. Lim SW; Jin L; Luo K; Jin J; Shin YJ; Hong SY; Yang CW Cell Death Dis; 2017 Aug; 8(8):e2972. PubMed ID: 28771227 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]